Celldex Therapeutics
CLDX
#4648
Rank
C$2.88 B
Marketcap
C$43.36
Share price
-1.45%
Change (1 day)
81.01%
Change (1 year)

Celldex Therapeutics (CLDX) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : C$77.42 Million

According to Celldex Therapeutics's latest financial reports the company's total liabilities are C$77.42 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celldex Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$76.44 M17.5%
2024-12-31C$65.05 M34.54%
2023-12-31C$48.35 M34.31%
2022-12-31C$36 M12.2%
2021-12-31C$32.08 M-4.97%
2020-12-31C$33.76 M-10.57%
2019-12-31C$37.75 M-12.7%
2018-12-31C$43.24 M-56.6%
2017-12-31C$99.64 M-37.12%
2016-12-31C$0.15 B140.62%
2015-12-31C$65.86 M56.12%
2014-12-31C$42.18 M45.17%
2013-12-31C$29.06 M-1.82%
2012-12-31C$29.6 M-0.59%
2011-12-31C$29.77 M-14.13%
2010-12-31C$34.67 M-50.52%
2009-12-31C$70.07 M11.56%
2008-12-31C$62.81 M499.28%
2007-12-31C$10.48 M-84.82%
2006-12-31C$69.06 M281.17%
2005-12-31C$18.11 M103.97%
2004-12-31C$8.88 M102.28%
2003-12-31C$4.39 M-28.5%
2002-12-31C$6.14 M-53.07%
2001-12-31C$13.08 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$168.37 B 217,365.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$113.64 B 146,677.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$84.36 B 108,862.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
C$0.36 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C$1.50 B 1,841.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.71 B 822.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.21 B 1,473.87%๐Ÿ‡บ๐Ÿ‡ธ USA